Zobrazeno 1 - 10 of 75 pro vyhledávání: '"Belluschi S"'
1
Akademický článek
Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of the cell cycle.
Autor: Johnson CS; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Cell Process Development, Cell and Gene Therapy, GlaxoSmithKline, Stevenage, United Kingdom., Williams M; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Sham K; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Belluschi S; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Ma W; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Wang X; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Lau WWY; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Kaufmann KB; Princess Margaret Cancer Center, University Health Network, Toronto, Canada., Krivdova G; Princess Margaret Cancer Center, University Health Network, Toronto, Canada., Calderbank EF; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Mende N; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., McLeod J; Princess Margaret Cancer Center, University Health Network, Toronto, Canada., Mantica G; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Li J; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Grey-Wilson C; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Drakopoulos M; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Basheer S; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Sinha S; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Diamanti E; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Basford C; Cell Process Development, Cell and Gene Therapy, GlaxoSmithKline, Stevenage, United Kingdom., Wilson NK; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Howe SJ; Cell Process Development, Cell and Gene Therapy, GlaxoSmithKline, Stevenage, United Kingdom., Dick JE; Princess Margaret Cancer Center, University Health Network, Toronto, Canada., Göttgens B; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Green AR; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Francis N; Cell Process Development, Cell and Gene Therapy, GlaxoSmithKline, Stevenage, United Kingdom.; Department of Gene Therapy and Regenerative Medicine, King's College London, London, United Kingdom., Laurenti E; Wellcome and Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Publikováno v: Blood [Blood] 2024 Aug 15; Vol. 144 (7), pp. 729-741.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia.
Autor: Magliulo D; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Simoni M; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Caserta C; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy., Fracassi C; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Belluschi S; Vita Salute San Raffaele University School of Medicine, Milan, Italy., Giannetti K; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy., Pini R; Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy., Zapparoli E; Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy., Beretta S; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy., Uggè M; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Draghi E; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Rossari F; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita Salute San Raffaele University School of Medicine, Milan, Italy., Coltella N; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy., Tresoldi C; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy., Morelli MJ; Center for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy., Di Micco R; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy., Gentner B; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy., Vago L; Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bernardi R; Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2023 Nov 08; Vol. 15 (11), pp. e17810. Date of Electronic Publication: 2023 Oct 09.
Zobrazit plný text záznamu
4
Akademický článek
Hematopoietic stem cells retain functional potential and molecular identity in hibernation cultures.
Autor: Oedekoven CA; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Belmonte M; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Bode D; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Hamey FK; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Shepherd MS; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Che JLC; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Boyd G; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK., McDonald C; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Belluschi S; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Diamanti E; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Bastos HP; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Bridge KS; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK., Göttgens B; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Laurenti E; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK., Kent DG; Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK; York Biomedical Research Institute, Department of Biology, University of York, York YO10 5DD, UK. Electronic address: david.kent@york.ac.uk.
Publikováno v: Stem cell reports [Stem Cell Reports] 2021 Jun 08; Vol. 16 (6), pp. 1614-1628. Date of Electronic Publication: 2021 May 06.
Zobrazit plný text záznamu
6
Akademický článek
Beyond "to divide or not to divide": Kinetics matters in hematopoietic stem cells.
Autor: Johnson C; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Belluschi S; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Laurenti E; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. Electronic address: el422@cam.ac.uk.
Publikováno v: Experimental hematology [Exp Hematol] 2020 Dec; Vol. 92, pp. 1-10.e2. Date of Electronic Publication: 2020 Nov 11.
Zobrazit plný text záznamu
7
Akademický článek
Extensive immunophenotypic sub-population analysis of StemRegenin1 expanded haematopoietic stem/progenitor cells.
Autor: Mellet, Juanita1 (AUTHOR), Hendricks, Candice L.1 (AUTHOR), Stivaktas, Voula2 (AUTHOR), Durandt, Chrisna1 (AUTHOR), Ambele, Melvin A.1,3 (AUTHOR), Pepper, Michael S.1 (AUTHOR) michael.pepper@up.ac.za
Publikováno v: Stem Cell Research & Therapy. 9/20/2024, Vol. 15 Issue 1, p1-18. 18p.
Zobrazit plný text záznamu
8
Akademický článek
Myelo-lymphoid lineage restriction occurs in the human haematopoietic stem cell compartment before lymphoid-primed multipotent progenitors.
Autor: Belluschi S; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Calderbank EF; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ciaurro V; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Pijuan-Sala B; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Santoro A; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Mende N; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Diamanti E; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Sham KYC; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Wang X; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Lau WWY; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Jawaid W; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Göttgens B; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Laurenti E; Department of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. el422@cam.ac.uk.
Publikováno v: Nature communications [Nat Commun] 2018 Oct 05; Vol. 9 (1), pp. 4100. Date of Electronic Publication: 2018 Oct 05.
Zobrazit plný text záznamu
9
News
Portland architect Belluschi’s widow dead at 88
Autor: DJC Staff
Publikováno v: Daily Journal of Commerce (Portland, OR). 03/04/2009.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje